PyInvesting

Market research

NTRP NextTrip Inc

NASDAQ USD Consumer Cyclical

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
19M
P/E ratio
Not available
Analyst target
6.8333
Dividend yield
Not available
Beta
1.71

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 4 months ago

Neurotrope, Inc is currently in a long term downtrend where the price is trading 16.6% below its 200 day moving average.

From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.

Neurotrope, Inc's total revenue sank by nan% to $0 since the same quarter in the previous year.

Its net income has dropped by 11.6% to $-4M since the same quarter in the previous year.

Finally, its free cash flow fell by 19.1% to $-3M since the same quarter in the previous year.

Based on the above factors, Neurotrope, Inc gets an overall score of 1/5.